JPMorgan Downgrades PTC Therapeutics (PTCT) to Neutral

March 2, 2015 7:18 AM

JPMorgan downgraded PTC Therapeutics (NASDAQ: PTCT) from Overweight to Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found